Jason Willis

2.8k total citations · 1 hit paper
51 papers, 1.1k citations indexed

About

Jason Willis is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jason Willis has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 22 papers in Cancer Research and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Jason Willis's work include Cancer Genomics and Diagnostics (21 papers), Colorectal Cancer Treatments and Studies (21 papers) and Genetic factors in colorectal cancer (16 papers). Jason Willis is often cited by papers focused on Cancer Genomics and Diagnostics (21 papers), Colorectal Cancer Treatments and Studies (21 papers) and Genetic factors in colorectal cancer (16 papers). Jason Willis collaborates with scholars based in United States, Italy and Canada. Jason Willis's co-authors include Eric C. Lai, Eugène Berezikov, Edwin Cuppen, Eduardo Vilar, Scott Kopetz, Kyle Chang, Laura Reyes-Uribe, Steven M. Lipkin, Christine M. Parseghian and Michael J. Overman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Jason Willis

43 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mammalian Mirtron Genes

2007 585 citations Eugène Berezikov, Jason Willis et al. Molecular Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason Willis United States	12	660	642	357	189	88	51	1.1k
Peiyong Guan Singapore	13	560 0.8×	308 0.5×	167 0.5×	130 0.7×	104 1.2×	26	897
Harald Surowy Germany	14	480 0.7×	407 0.6×	168 0.5×	134 0.7×	118 1.3×	28	745
Atsuko Katagiri Japan	17	621 0.9×	231 0.4×	205 0.6×	220 1.2×	96 1.1×	37	956
Chaitanya Bandlamudi United States	12	358 0.5×	318 0.5×	255 0.7×	115 0.6×	191 2.2×	28	827
Koichi Suzuki Japan	18	452 0.7×	288 0.4×	333 0.9×	216 1.1×	205 2.3×	58	853
Hans Konrad Schackert Germany	14	466 0.7×	280 0.4×	333 0.9×	244 1.3×	46 0.5×	16	878
Alexander Penson United States	10	451 0.7×	353 0.5×	363 1.0×	91 0.5×	319 3.6×	12	904
Andrea O’Hara United States	7	515 0.8×	379 0.6×	309 0.9×	105 0.6×	52 0.6×	13	812
Raphaela Schwentner Austria	19	565 0.9×	276 0.4×	222 0.6×	122 0.6×	344 3.9×	30	1.0k
David Brocks Germany	10	584 0.9×	266 0.4×	151 0.4×	61 0.3×	94 1.1×	14	807

Countries citing papers authored by Jason Willis

Since Specialization

Citations

This map shows the geographic impact of Jason Willis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Willis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Willis more than expected).

Fields of papers citing papers by Jason Willis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Willis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Willis. The network helps show where Jason Willis may publish in the future.

Co-authorship network of co-authors of Jason Willis

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Willis. A scholar is included among the top collaborators of Jason Willis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Willis. Jason Willis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

White, Michael G., John Paul Shen, Eduardo Vilar, et al.. (2025). Mutational and co-mutational landscape of early onset colorectal cancer. Biomarkers. 30(1). 64–76. 6 indexed citations

Österlund, Emerik, Andrew J. Pellatt, Christine M. Parseghian, et al.. (2025). 732MO Circulating tumour DNA (ctDNA) clearance and correlation with outcome in the INTERCEPT colorectal cancer (CRC) study. Annals of Oncology. 36. S480–S480. 1 indexed citations

Folkert, Ian W., Reza J. Mehran, Van K. Morris, et al.. (2025). Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial. Annals of Surgical Oncology. 33(4). 2899–2907.

Vilar, Eduardo, Jason Willis, Michael J. Hall, et al.. (2024). 638 Nous-209 vaccine induces shared neoantigen immunogenicity for cancer interception in healthy lynch syndrome carriers: results from phase Ib/II trial. Regular and Young Investigator Award Abstracts. A732–A732. 1 indexed citations

Yousef, Abdelrahman, Mark W. Hurd, Huamin Wang, et al.. (2024). Molecular and clinical features of pancreatic acinar cell carcinoma: A single institutional experience.. Journal of Clinical Oncology. 42(16_suppl). e16335–e16335.

Pellatt, Andrew J., Christine M. Parseghian, Kathryn E. Aziz, et al.. (2024). Redefining the prognostic significance of RAS and BRAF V600E mutations on disease free survival in patients with colorectal cancer in the era of ct-DNA defined minimal residual disease: Results from the MD Anderson INTERCEPT Program.. Journal of Clinical Oncology. 42(3_suppl). 196–196.

Raghav, Kanwal, Lianchun Xiao, Courtney Lewis, et al.. (2024). A randomized study evaluating tailoring of advanced/metastatic colorectal cancer (mCRC) therapy using circulating tumor DNA (ctDNA): TACT-D.. Journal of Clinical Oncology. 42(17_suppl). LBA3557–LBA3557.

Loree, Jonathan M., Arvind Dasari, Jason Willis, et al.. (2024). Racial/ethnic representation and disparities in preclinical cancer models.. Journal of Clinical Oncology. 42(16_suppl). 1601–1601.

Thomas, Jane V., Kaysia Ludford, Jason Willis, et al.. (2023). Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer Research Communications. 3(12). 2510–2517. 4 indexed citations

10.

Napolitano, Stefania, Aparna R. Parikh, Jason T. Henry, et al.. (2023). Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing. JCO Precision Oncology. 7(7). e2300228–e2300228. 1 indexed citations

11.

De, Brian, Marcus A. Florez, Sunyoung S. Lee, et al.. (2023). Dose-escalated pancreas radiotherapy for unresected pancreatic adenocarcinoma: Patterns of care and survival in the United States.. Journal of Clinical Oncology. 41(4_suppl). 676–676. 1 indexed citations

12.

Rogers, Jane E., Hyunsoo Hwang, Wei Qiao, et al.. (2022). Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience. The Oncologist. 27(11). 952–957. 14 indexed citations

13.

Parseghian, Christine M., Ryan Sun, Stefania Napolitano, et al.. (2022). Resistance Mechanisms to Anti–Epidermal Growth Factor Receptor Therapy in RAS/RAF Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy. Journal of Clinical Oncology. 41(3). 460–471. 41 indexed citations

14.

Sarshekeh, Amir Mehrvarz, Jason Roszik, Ganiraju C. Manyam, et al.. (2021). ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 27(6). 1663–1670. 40 indexed citations

15.

Chang, Kyle, Jason Willis, Joke Reumers, et al.. (2018). Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. Annals of Oncology. 29(10). 2061–2067. 38 indexed citations

16.

Willis, Jason, Marlyn J. Mayo, Thomas E. Rogers, & Weina Chen. (2008). Hereditary haemorrhagic telangiectasia involving the bone marrow and liver. British Journal of Haematology. 145(2). 150–150. 2 indexed citations

17.

Berezikov, Eugène, et al.. (2007). Mammalian Mirtron Genes. Molecular Cell. 28(2). 328–336. 585 indexed citations breakdown →

18.

Tringe, Susannah G., Jason Willis, Katie L. Liberatore, & Stephanie W. Ruby. (2006). The WTM Genes in Budding Yeast Amplify Expression of the Stress-Inducible Gene RNR3. Genetics. 174(3). 1215–1228. 5 indexed citations

19.

Kim, Walter, et al.. (2006). Duodenal Gastric Duplication Cyst Detection After Roux-en-Y Decompression Using Tc-99m Pertechnetate. Clinical Nuclear Medicine. 31(3). 164–165.

20.

Willis, Jason. (1997). Women's cancers.. PubMed. 93(40). 26–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact